CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C05804 | BRD-K10923439 | BRD-K10923439 | -- | -- | -- | Details |
| C05805 | BRD-K10925833 | BRD-K10925833 | -- | -- | -- | Details |
| C05806 | BRD-K10927790 | BRD-K10927790 | -- | -- | -- | Details |
| C05807 | BRD-K10937407 | BRD-K10937407 | -- | -- | -- | Details |
| C05808 | BRD-K10938308 | BRD-K10938308 | -- | -- | -- | Details |
| C05809 | BRD-K10939925 | BRD-K10939925 | -- | -- | -- | Details |
| C05810 | BRD-K10943878 | BRD-K10943878 | -- | -- | -- | Details |
| C05811 | BRD-K10946493 | SA-424371 | -- | -- | -- | Details |
| C05812 | BRD-K10951564 | BRD-K10951564 | -- | -- | -- | Details |
| C05813 | BRD-K10954923 | BRD-K10954923 | -- | -- | -- | Details |
| C05814 | BRD-K10958118 | L-778123 | -- | -- | -- | Details |
| C05815 | BRD-K10959171 | BRD-K10959171 | -- | -- | -- | Details |
| C05816 | BRD-K10961822 | latanoprost | PTGFR | Prostanoid receptor agonist | -- | Details |
| C05817 | BRD-K10974103 | diloxanide | -- | -- | -- | Details |
| C05818 | BRD-K10987837 | BRD-K10987837 | -- | -- | -- | Details |
| C05819 | BRD-K10989535 | BRD-K10989535 | -- | -- | -- | Details |
| C05820 | BRD-K10989739 | BRD-K10989739 | -- | -- | -- | Details |
| C05821 | BRD-K10990317 | clotiapine | -- | -- | -- | Details |
| C05822 | BRD-K10991887 | BRD-K10991887 | -- | -- | -- | Details |
| C05823 | BRD-K10995081 | perphenazine | DRD2 | Dopamine receptor antagonist | -- | Details |
| C05824 | BRD-K11002182 | BRD-K11002182 | -- | -- | -- | Details |
| C05825 | BRD-K11003742 | BRD-K11003742 | -- | -- | -- | Details |
| C05826 | BRD-K11004561 | BRD-K11004561 | -- | -- | -- | Details |
| C05827 | BRD-K11006288 | BRD-K11006288 | -- | -- | -- | Details |
| C05828 | BRD-K11008696 | BRD-K11008696 | -- | -- | -- | Details |
| C05829 | BRD-K11010670 | BRD-K11010670 | -- | -- | -- | Details |
| C05830 | BRD-K11013450 | BRD-K11013450 | -- | -- | -- | Details |
| C05831 | BRD-K11015688 | KU-C104256 | -- | -- | -- | Details |
| C05832 | BRD-K11016405 | BRD-K11016405 | -- | -- | -- | Details |
| C05833 | BRD-K11019021 | BRD-K11019021 | -- | -- | -- | Details |
| C05834 | BRD-K11022579 | BRD-K11022579 | -- | -- | -- | Details |
| C05835 | BRD-K11022796 | BRD-K11022796 | -- | -- | -- | Details |
| C05836 | BRD-K11027431 | BRD-K11027431 | -- | -- | -- | Details |
| C05837 | BRD-K11030235 | BRD-K11030235 | -- | -- | -- | Details |
| C05838 | BRD-K11031937 | BRD-K11031937 | -- | -- | -- | Details |
| C05839 | BRD-K11054031 | BRD-K11054031 | -- | -- | -- | Details |
| C05840 | BRD-K11054415 | BRD-K11054415 | -- | -- | -- | Details |
| C05841 | BRD-K11054980 | BRD-K11054980 | -- | -- | -- | Details |
| C05842 | BRD-K11055147 | BRD-K11055147 | -- | -- | -- | Details |
| C05843 | BRD-K11056481 | BRD-K11056481 | -- | -- | -- | Details |
| C05844 | BRD-K11057086 | BRD-K11057086 | -- | -- | -- | Details |
| C05845 | BRD-K11062991 | BRD-K11062991 | -- | -- | -- | Details |
| C05846 | BRD-K11068374 | BRD-K11068374 | -- | -- | -- | Details |
| C05847 | BRD-K11071038 | ICI-162846 | HRH2 | Histamine receptor antagonist | -- | Details |
| C05848 | BRD-K11071576 | BRD-K11071576 | -- | -- | -- | Details |
| C05849 | BRD-K11072542 | BRD-K11072542 | -- | -- | -- | Details |
| C05850 | BRD-K11073688 | CPI-1189 | TNF | Tumor necrosis factor release inhibitor | -- | Details |
| C05851 | BRD-K11081110 | BRD-K11081110 | -- | -- | -- | Details |
| C05852 | BRD-K11088254 | BRD-K11088254 | -- | -- | -- | Details |
| C05853 | BRD-K11089039 | BRD-K11089039 | -- | -- | -- | Details |
| C05854 | BRD-K11092807 | BRD-K11092807 | -- | -- | -- | Details |
| C05855 | BRD-K11093795 | BRD-K11093795 | -- | -- | -- | Details |
| C05856 | BRD-K11095218 | BRD-K11095218 | -- | -- | -- | Details |
| C05857 | BRD-K11095531 | BRD-K11095531 | -- | -- | -- | Details |
| C05858 | BRD-K11097458 | BRD-K11097458 | -- | -- | -- | Details |
| C05859 | BRD-K11105500 | BRD-K11105500 | -- | -- | -- | Details |
| C05860 | BRD-K11107424 | tiotidine | HRH2 | Histamine receptor antagonist | -- | Details |
| C05861 | BRD-K11112971 | BRD-K11112971 | -- | -- | -- | Details |
| C05862 | BRD-K11113009 | BRD-K11113009 | -- | -- | -- | Details |
| C05863 | BRD-K11117868 | BRD-K11117868 | -- | -- | -- | Details |
| C05864 | BRD-K11129031 | gemfibrozil | CYP2C8; LPL; PPARA | Lipoprotein lipase activator | -- | Details |
| C05865 | BRD-K11133230 | BRD-K11133230 | -- | -- | -- | Details |
| C05866 | BRD-K11141556 | BRD-K11141556 | -- | -- | -- | Details |
| C05867 | BRD-K11143221 | BRD-K11143221 | -- | -- | -- | Details |
| C05868 | BRD-K11144279 | BRD-K11144279 | -- | -- | -- | Details |
| C05869 | BRD-K11145711 | BRD-K11145711 | -- | -- | -- | Details |
| C05870 | BRD-K11147885 | BRD-K11147885 | -- | -- | -- | Details |
| C05871 | BRD-K11153516 | iniparib | PARP1 | PARP inhibitor | -- | Details |
| C05872 | BRD-K11156132 | BRD-K11156132 | -- | -- | -- | Details |
| C05873 | BRD-K11158154 | BRD-K11158154 | -- | -- | -- | Details |
| C05874 | BRD-K11158509 | tyrphostin-B44 | -- | -- | TYRPHOSTIN-B44 | Details |
| C05875 | BRD-K11163873 | phenanthridone | PARP1 | PARP inhibitor | -- | Details |
| C05876 | BRD-K11165361 | BRD-K11165361 | -- | -- | -- | Details |
| C05877 | BRD-K11168234 | BRD-K11168234 | -- | -- | -- | Details |
| C05878 | BRD-K11169037 | BRD-K11169037 | -- | -- | -- | Details |
| C05879 | BRD-K11171096 | BRD-K11171096 | -- | -- | -- | Details |
| C05880 | BRD-K11172604 | BRD-K11172604 | -- | -- | -- | Details |
| C05881 | BRD-K11180501 | BRD-K11180501 | -- | -- | -- | Details |
| C05882 | BRD-K11181277 | BRD-K11181277 | -- | -- | -- | Details |
| C05883 | BRD-K11187612 | BRD-K11187612 | -- | -- | -- | Details |
| C05884 | BRD-K11188962 | BRD-K11188962 | -- | -- | -- | Details |
| C05885 | BRD-K11194815 | BRD-K11194815 | -- | -- | -- | Details |
| C05886 | BRD-K11196887 | norfloxacin | -- | -- | -- | Details |
| C05887 | BRD-K11215326 | E-7438 | -- | -- | tazemetostat | Details |
| C05888 | BRD-K11218457 | BRD-K11218457 | -- | -- | -- | Details |
| C05889 | BRD-K11219023 | BRD-K11219023 | -- | -- | -- | Details |
| C05890 | BRD-K11221750 | BRD-K11221750 | -- | -- | -- | Details |
| C05891 | BRD-K11224669 | BRD-K11224669 | -- | -- | -- | Details |
| C05892 | BRD-K11227160 | BRD-K11227160 | -- | -- | -- | Details |
| C05893 | BRD-K11231529 | BRD-K11231529 | -- | -- | -- | Details |
| C05894 | BRD-K11236606 | BRD-K11236606 | -- | -- | -- | Details |
| C05895 | BRD-K11238413 | BRD-K11238413 | -- | -- | -- | Details |
| C05896 | BRD-K11242872 | BRD-K11242872 | -- | -- | -- | Details |
| C05897 | BRD-K11246802 | BRD-K11246802 | -- | -- | -- | Details |
| C05898 | BRD-K11247495 | BRD-K11247495 | -- | -- | -- | Details |
| C05899 | BRD-K11251396 | BRD-K11251396 | -- | -- | -- | Details |
| C05900 | BRD-K11258147 | BRD-K11258147 | -- | -- | -- | Details |
| C05901 | BRD-K11258719 | BRD-K11258719 | -- | -- | -- | Details |
| C05902 | BRD-K11259871 | BRD-K11259871 | -- | -- | -- | Details |
| C05903 | BRD-K11260407 | BRD-K11260407 | -- | -- | -- | Details |